Brind.

Mesoblast received FDA approval for a specific product on June 1st, led by CEO Silviu Itescu.

1 report, 1 independent Updated Jun 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Mesoblast Silviu Itescu FDA

Keep exploring

The entities involved

Mesoblast
pharmaceutical company
- Trump pledged to unleash American oil and gas production.Sun 15:33
- Mesoblast is seeking FDA review of the BLA for its product rexlemestrocel-L.Thu 12:51
Silviu Itescu
researcher

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

Coverage

Newest first; wire copies grouped

Jun 1manilatimes.net